TY - JOUR
T1 - Introduction
T2 - On-label and off-label drug use in reproductive medicine
AU - Legro, Richard S.
N1 - Publisher Copyright:
© 2015 American Society for Reproductive Medicine.
PY - 2015/3/1
Y1 - 2015/3/1
N2 - This Views and Reviews article examines FDA-approved uses of prescription drugs, as well as common off-label uses of drugs for several disorders that are frequently seen in reproductive medicine. Off-label drug use is ubiquitous in reproductive medicine, a fact that may be related to the disincentives to formally study these drugs in a potentially vulnerable population (i.e., pregnant women). It behooves clinicians to discuss with patients the risk-benefit ratio of treatment, and whether a treatment is FDA-approved for that condition. Researchers, seeking better data on effects of these drugs, may find fodder for future clinical studies in these articles.
AB - This Views and Reviews article examines FDA-approved uses of prescription drugs, as well as common off-label uses of drugs for several disorders that are frequently seen in reproductive medicine. Off-label drug use is ubiquitous in reproductive medicine, a fact that may be related to the disincentives to formally study these drugs in a potentially vulnerable population (i.e., pregnant women). It behooves clinicians to discuss with patients the risk-benefit ratio of treatment, and whether a treatment is FDA-approved for that condition. Researchers, seeking better data on effects of these drugs, may find fodder for future clinical studies in these articles.
UR - http://www.scopus.com/inward/record.url?scp=84926064059&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84926064059&partnerID=8YFLogxK
U2 - 10.1016/j.fertnstert.2015.01.028
DO - 10.1016/j.fertnstert.2015.01.028
M3 - Article
C2 - 25726701
AN - SCOPUS:84926064059
SN - 0015-0282
VL - 103
SP - 581
EP - 582
JO - Fertility and sterility
JF - Fertility and sterility
IS - 3
ER -